Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (4244)	3/6/2000 2:41:00 PM
From: Biomaven	Read Replies (1) of 10280

David, We also saw another asthma release from IMNX. If anything, it looked more promising than the DNA/Tanox product. My take on these announcements is that they shouldn't have a huge impact on SEPR unless something really dramatic is discovered. They are likely to be principally steroid replacements/supplements, and probably won't have a huge impact on the growth rate for acute treatments. The SEPR pipeline basically depends on substituting for existing acute treatments by albuterol and the longer-lasting variants. These new treatments are likely to be expensive and reserved mainly for the most serious cases. Xopenex is a broad-based, comparatively cheap drug. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next